CVSGF (CVSGF)

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CVS Health (CVS) has moved to expand access to GLP-1 weight management drugs by reintroducing Zepbound and easing access to new oral therapy Foundayo, as regulators and courts scrutinize its pharmacy benefit practices. See our latest analysis for CVS Health. The recent formulary decisions on ...

CVS Health (CVS) has drawn fresh attention after recent share price gains, with the stock up about 11.7% over the past week and roughly 10.4% over the past month. This has prompted closer scrutiny from investors. See our latest analysis for CVS Health. Those short term gains sit within a stronger ..…

CVS Health has outpaced the S&P 500 Index over the past year, and analysts are highly optimistic about the stock’s prospects.

CVS Health (CVS-N, Monday’s close US$97.08) declined from US$111.25 in February, 2022, to about US$65 in 2023 (A–B), then transitioned into a multi-year base-building phase lasting roughly three years. During this period, the stock formed a bullish Inverse Head-and-Shoulders pattern (solid ...